The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial.
 
Jun Ma
Research Funding - Bristol Myers Squibb Foundation; Varian Medical Systems
 
Ying Sun
No Relationships to Disclose
 
Ye-Lin Liang
No Relationships to Disclose
 
Xu Liu
No Relationships to Disclose
 
Liangfang Shen
No Relationships to Disclose
 
Weihan Hu
No Relationships to Disclose
 
Guangyuan Hu
No Relationships to Disclose
 
Fangyun Xie
No Relationships to Disclose
 
Ying Huang
No Relationships to Disclose
 
Guorong Zou
No Relationships to Disclose
 
Ning Zhang
No Relationships to Disclose
 
Chuanben Chen
No Relationships to Disclose
 
Xiaozhong Chen
No Relationships to Disclose
 
Xiaodong Zhu
No Relationships to Disclose
 
Yawei Yuan
No Relationships to Disclose
 
Kunyu Yang
No Relationships to Disclose
 
Feng Jin
No Relationships to Disclose
 
Shu-Bin Hong
No Relationships to Disclose
 
Hongyun Zhao
No Relationships to Disclose
 
Ji-Bin Li
No Relationships to Disclose